机构:[1]State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong, China.[2]Department of Ophthalmology, Chengdu First People's Hospital, Chengdu, Sichuan, China[3]Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, Japan[4]Department of Ophthalmology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China[5]Department of Ophthalmology, West China Hospital of Sichuan University, Chengdu, Sichuan, China四川大学华西医院[6]Jinan Mingshui Eye Hospital, Jinan, Shandong, China[7]Department of Ophthalmology, Handan City Eye Hospital (The Third Hospital of Handan), Handan, Hebei, China[8]Cangzhou Aier Eye Hospital, Aier Eye Hospital Group, Cangzhou, Hebei, China[9]Department of Ophthalmology, Shijiazhuang People's Hospital, Shijiazhuang, Hebei, China[10]Department of Ophthalmology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China[11]Department of Ophthalmology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, Shandong, China[12]Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China首都医科大学附属北京同仁医院首都医科大学附属同仁医院[13]Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.[14]NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, London, UK[15]Singapore Eye Research Institute, Singapore National Eye Center, Singapore, Republic of Singapore[16]International Eye Research Institute of The Chinese University of Hong Kong (Shenzhen), Shenzhen, China[17]Hamilton Glaucoma Center, Viterbi Family Department of Ophthalmology, and Shiley Eye Institute, University of California San Diego, La Jolla, CA, USA
Supported by the National Key R&D Program of China
(2022YFC2502800); the National Natural Science Foundation of China (81670860);
the Project of Chengdu Science and Technology Bureau (No. 2021-YF05-00649-SN);
the National Natural Science Foundation of China (No. 81670860); the Chongqing
Natural Research Foundation (No. cstc 2018jcyjAX0034); the Cangzhou Key Research
and Development Plan Guidance Project (No. 213106140).
第一作者机构:[1]State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong, China.
共同第一作者:
通讯作者:
通讯机构:[1]State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong, China.[2]Department of Ophthalmology, Chengdu First People's Hospital, Chengdu, Sichuan, China[*1]Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-sen University, No.7, Jinsui Road, Guangzhou 510060, China[*2]Department of Ophthalmology, Chengdu First People's Hospital, Chengdu 610000, China
推荐引用方式(GB/T 7714):
Yu Zhang,Ping Yu,Yingzhe Zhang,et al.Influence of Goniotomy Size on Treatment Safety and Efficacy for Primary Open-Angle Glaucoma: A Multicenter Study[J].AMERICAN JOURNAL OF OPHTHALMOLOGY.2023,256:118-125.doi:10.1016/j.ajo.2023.08.002.
APA:
Yu Zhang,Ping Yu,Yingzhe Zhang,Kazunobu Sugihara,Xiaomin Zhu...&Xiulan Zhang.(2023).Influence of Goniotomy Size on Treatment Safety and Efficacy for Primary Open-Angle Glaucoma: A Multicenter Study.AMERICAN JOURNAL OF OPHTHALMOLOGY,256,
MLA:
Yu Zhang,et al."Influence of Goniotomy Size on Treatment Safety and Efficacy for Primary Open-Angle Glaucoma: A Multicenter Study".AMERICAN JOURNAL OF OPHTHALMOLOGY 256.(2023):118-125